Human esophageal squamous cell carcinoma cells (KYSE-150-Luc)

The KYSE-150-Luc human esophageal squamous cell carcinoma cells are a vital resource for cancer research enabling scientists to study the mechanisms of esophageal cancer progression and response to therapies in a controlled laboratory environment Utilizing dry ice preservation and T25 live cell transportation ensures that these epithelial adherent cells remain viable allowing for seamless experimentation and analysis upon arrival at research facilities

In therapeutic development the KYSE-150-Luc cells serve as an invaluable tool for screening potential anti-cancer agents helping researchers evaluate the efficacy of novel drugs in targeting esophageal cancer cells with a luminescent reporter for real-time monitoring of cellular responses Moreover their consistent supply in a specific diluent mixture of 90% RPMI-1640 with 10% FBS supports optimal growth conditions facilitating long-term studies on cell behavior and treatment resistance

Ultimately these cells contribute to enhancing our understanding of esophageal squamous cell carcinoma paving the way for innovative treatment strategies and improving patient outcomes through better-informed clinical approaches